About: Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	assaig clínic (ca) clinical trial (en) clinical trial (en-ca) clinical trial (en-gb) clinical trial (en-us) ensaio clínico (gl) ensayo clínico (es) ensayu clínicu (ast) essai clinique (fr) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy (en) Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy (nl)
skos:prefLabel	Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy (en) Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy (nl)
name	Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy (en) Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy (nl)
title	wds:Q65389835-14A90525-5F8C-4C6D-B122-14A7485F9FE8
title	A Randomized, Controlled, Open-Label Parallel Group Study to Evaluate the Effect of Regularly Scheduled Neutralizing Antibody Testing on Treatment Patterns Versus Usual Care in High-Dose Interferon Treated Patients (en)
end time	wds:Q65389835-1FC3E867-195E-4059-8F1F-E01EF230731A
end time	2009-04-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q65389835-E56497D8-7087-48B6-91AF-2EAADA563C71
instance of	clinical trial
start time	wds:Q65389835-2B623A6A-54FE-4CF1-B8F9-418376D179BB
start time	2006-07-01 00:00:00Z (xsd:dateTime)
country	wds:Q65389835-A418E89F-63F0-4680-A344-0DCFB8F6FCF2
country	United States of America
research site	wds:Q65389835-14233E7D-15DF-412D-BE30-F85F0D2B1209 wds:Q65389835-241A0106-6441-47EA-9F0D-13B1E446E1AC wds:Q65389835-3A262352-173E-4D73-93D7-4143ABD7CE7A wds:Q65389835-4F434FC9-C081-4C6C-8B9A-A751B56487E7 wds:Q65389835-712CCB2D-D516-47BE-82D5-2FC523A83442 wds:Q65389835-893C4ECB-7426-48B5-9D9E-700E10561B44 wds:Q65389835-9B54F14D-1DE2-4F33-A285-27BF3B79FE47 wds:Q65389835-E7C6CCCC-5222-41D3-93D9-48AB5FD5DD48 wds:Q65389835-FA2ED467-E940-4AA2-8683-CC0EC1859EC7
research site	Lahey Clinic University of Southern California University of California, Davis University of South Florida Axiom Clinical Research of Florida Raleigh Neurology Associates Central Texas Neurology Consultants Phoenix Neurological Associates Dean Health Systems
minimum age	wds:Q65389835-25DFCDFA-FC02-4C03-AD8D-DA063A18245E
minimum age	18 (xsd:decimal)
medical condition	wds:Q65389835-DE214C18-F11E-4A22-B5BD-27C555EE351A
medical condition	multiple sclerosis
number of participants	wds:Q65389835-8556A9AD-A1BE-4A53-8E08-0C225BA133C1
number of participants	1230 (xsd:decimal)
study type	wds:Q65389835-7AA2C95F-E6F3-41AE-AA5E-9B0862375855
study type	observational study
ClinicalTrials.gov ID	wds:Q65389835-B52604DA-F1CD-4D60-A739-8B488C7B12A5
ClinicalTrials.gov ID	NCT00336557
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65389835

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software